A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors
type: MedicalStudy
description: A Multicenter, Randomized, Controlled Phase IIa Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2021-10-09
end date: 2023-05-17
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT05839639
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Huahui Health
study subject: Chronic Hepatitis B
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Chronic Hepatitis B

AI Analytics
type: Organization